Suchergebnisse - "Sanne, Ian"

PubPharm (12)

1

Impact of choice of NRTI in first-line antiretroviral therapy : a cohort analysis of stavudine vs. tenofovir

enthalten in: Tropical medicine & international health : TM & IH | 2014

von Brennan, A. | Shearer, K. | Maskew, M. | +3

CommentIn: Trop Med Int Health. 2014 May;19(5):499-500. - PMID 24646005

2

Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals

enthalten in: AIDS (London, England) | 2012

von Azzoni, L. | Foulkes, A. | Firnhaber, C. | +8

3

Effectiveness and safety of 30 mg versus 40 mg stavudine regimens : a cohort study among HIV-infected adults initiating HAART in South Africa

enthalten in: Journal of the International AIDS Society | 2012

von Maskew, M. | Westreich, D. | Fox, M. | +2

4

Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy

enthalten in: Antiviral therapy | 2012

von Wallis, C. | Papathanasopolous, M. | Fox, M. | +55

5

A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects

enthalten in: BMC infectious diseases | 2011

von Menezes, C. | Maskew, M. | Sanne, I. | +2

6

Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infection

enthalten in: PloS one | 2011

von Firnhaber, C. | Azzoni, L. | Foulkes, A. | +11

7

Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients : a randomized trial

enthalten in: Archives of internal medicine | 2009

von Gross, R. | Tierney, C. | Andrade, A. | +73

CommentIn: Arch Intern Med. 2010 Jan 11;170(1):109-10. - PMID 20065210

8

Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2009

von Westreich, D. | Sanne, I. | Maskew, M. | +7

9

Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2008

von Rosen, S. | Long, L. | Fox, M. | +1

10

Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients

enthalten in: The Journal of infectious diseases | 2004

von King, M. | Bernstein, B. | Walmsley, S. | +7